Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Sparking collaborations and discussions on substandard and falsified medicines at MQPH 2018

Over 200 delegates traveled from more than 50 countries to attend the first ever conference on Medicine Quality and Public Health (MQPH) in Oxford from 23-28 September 2018. The conference brought together experts from academia, public health, pharmacy, chemistry, law, ethics, social sciences, public engagement, health policy, with national medicines regulatory authorities, NGOs, international organizations and donors. Conference partners presented the latest evidence on substandard, falsified and unregulated medicines, and discussed strategies to tackle this global challenge.

Group photo of MQPH 2018 participants

The full story is available on the WWARN website

Similar stories

Medicine Quality Research Group awarded £3.7 million to evaluate devices for detecting substandard and falsified vaccines

The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on innovative screening devices for detecting degraded and falsified vaccines.

Congratulations to our new Associate Professors 2026

Our heartfelt congratulations to Cindy Chu, Liz Batty and Tom Peto who have been awarded Associate Professorships

30 years of MORU research in Rickettsioses featured in ESCMID 2026 keynote

MORU was well represented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2026 conference, held from 17-21 April in Munich.

MODRA Cohort 2: From ideas to action

Following the success of the first MODRA workshop in September, where participants developed strong research grant proposals, the MODRA Cohort 2 researchers reconvened at OUCRU Ho Chi Minh City for Workshop 2, focused on taking their projects from paper to practice.

Ensitrelvir shows strong antiviral activity against COVID-19 in first head-to-head comparison with Paxlovid

The oral antiviral ensitrelvir is a highly effective treatment for COVID-19, showing potent in-vivo antiviral activity comparable to ritonavir-boosted nirmatrelvir (Paxlovid), say MORU, Mahidol and University of Oxford researchers in a major international study published in The Lancet Infectious Diseases.

Two nights of talks for Pint of Science Laos 2025

In May 2025, LOMWRU organised the 4th Pint of Science event in Vientiane, Laos, as part of the global Pint of Science festival. The successful event, open to the general public, had local researchers from public health, wildlife conservation, and geology giving fun and interesting talks over two nights, giving insights into how their work impacts Laos.